TAmiRNA is a biotechnology company specializing in the discovery and development of microRNA biomarkers. MicroRNA Biomarker Discovery and Development: TAmiRNA operates a research and development laboratory equipped for high-throughput screening of microRNA transcript levels in various biological samples. They have protocols for isolating microvesicles and RNA, using locked-nucleic-acid (LNA) based qPCR and next-generation sequencing technologies. Collaborations with Grillari Labs and Evercyte support testing the biological function of microRNAs for diagnosis, prognosis, treatment monitoring, and drug development. HepatomiR is designed to identify the presence of biomarkers of liver function and disease. Future Expansion: TAmiRNA is also developing early-stage projects in liver disease, cancer, and aging, and is actively seeking to expand its product and technology pipeline through in-licensing of intellectual property from academia and industry.